pyridinolcarbamate has been researched along with Cholangitis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gal'perin, EI | 1 |
| Tatishvili, GG | 1 |
| Akhaladze, GG | 1 |
| Sakevarashvili, GR | 1 |
| Nasirov, FN | 1 |
| Aref'ev, AE | 1 |
1 other study available for pyridinolcarbamate and Cholangitis
| Article | Year |
|---|---|
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyr | 1991 |